Adial Pharmaceuticals Headquarters
Looking for information about Adial Pharmaceuticals Headquarters? The links below have collected all the necessary data.
Adial Pharmaceuticals Company Profile - Office Locations ...
- https://craft.co/adial-pharmaceuticals
- May 17, 2021 · Adial Pharmaceuticals headquarters is located at 204 E High St, Charlottesville. Where are Adial Pharmaceuticals offices? Adial Pharmaceuticals has an office in Charlottesville. How many offices does Adial Pharmaceuticals have? Adial Pharmaceuticals has 2 offices. Learn about Craft real-time company insights.Employees: 3
Adial Pharmaceuticals Inc. Medicines for Addiction
- https://www.adialpharma.com/
- Jun 24, 2021 · Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the treatment and prevention of addictions. The Company’s lead investigational new drug product, AD04, is currently in Phase 3 development as a genetically targeted therapeutic agent for the treatment of Alcohol Use Disorder (AUD).
Adial Pharmaceuticals (nasdaq: Adil) - Email & Phone of ...
- https://www.easyleadz.com/company/adial-pharmaceuticals-nasdaq:-adil
- Adial Pharmaceuticals (nasdaq: Adil) is a Pharmaceuticals company and has headquarters in Charlottesville, Virginia, United States. Adial Pharmaceuticals (nasdaq: Adil) specialises in pharmaceuticals.
Adial Pharmaceuticals, Inc.
- https://adiaslpharma.com/
- Jul 22, 2021 · Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the treatment and prevention of addictions. The Company’s lead investigational new drug product, AD04, is currently in Phase 3 development as a genetically targeted therapeutic agent for the treatment of Alcohol Use Disorder (AUD).
Adial Pharmaceuticals - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/adial-pharmaceuticals
- Adial Pharmaceuticals, LLC engages in the development of prescription medications for addiction and related disorders in the United States. The company's research pipeline includes AD04, a compound that completed Phase IIb study for the treatment of alcohol use disorders; and AD01, which completed Phase I clinical-stage for treating addictiveFounders: Bankole Johnson, William B Stilley
Company Information :: Adial Pharmaceutical, Inc. (ADIL)
- https://ir.adialpharma.com/company-information
- Adial Pharmaceuticals, Inc. ("the Company") is a clinical-stage biopharmaceutical company focused on the development of a therapeutic agent for the treatment of alcohol use disorder ("AUD") using its lead investigational new drug product, AD04, a selective serotonin-3 antagonist (i.e., a "5-HT3 antagonist").
Adial Pharmaceuticals (NASDAQ: ADIL) LinkedIn
- https://www.linkedin.com/company/adialpharma
- Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of pharmaceuticals for the treatment and prevention of addictions. The Company’s lead ...
Adial Pharmaceutical, Inc. (ADIL)
- https://ir.adialpharma.com/
- Adial Pharmaceuticals, Inc. ("the Company") is a clinical-stage biopharmaceutical company focused on the development of a therapeutic agent for the treatment of alcohol use disorder ("AUD") using its lead investigational new drug product, AD04, a selective serotonin-3 antagonist (i.e., a "5-HT3 antagonist").
Adial Pharmaceuticals Inc. MANAGEMENT
- https://www.adialpharma.com/about/management/
- William B. Stilley has served as our Chief Executive Officer since co-founding the company in December 2010. Prior to joining Adial Pharmaceuticals, he was the Vice President, Business Development & Strategic Projects at Clinical Data, Inc. (NASDQ CLDA), where he worked on licensing and M&A transactions and was involved in management of Phase 3 clinical trials, production of Viibryd ® for ...
Have you found Adial Pharmaceuticals Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.